American Journal of Tropical Medicine and Hygiene Publishes Recommendations for Safe and Ethical Testing of Gene Drive Mosquitoes to Reduce Malaria Transmission in Africa
June 7, 2018 — The American Journal of Tropical Medicine and Hygiene (AJTMH) has published an article outlining recommendations for the safe and ethical testing of gene drive technology on mosquitoes to reduce the burden of malaria transmission in Africa.
The FNIH Biomarkers Consortium Launches Project to Improve Diagnosis and Treatment of Neurodegenerative and Psychiatric Diseases
April 26, 2018 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a project, under its Neuroscience Steering Committee, with the potential to improve diagnosis and the development of targeted therapies for Alzheimer’s Disease (AD) and Major Depressive Disorder (MDD). Research continues to strengthen the connection between inflammatory processes in the brain with the development and progression of multiple central nervous system (CNS) disorders, including AD and MDD.
December 7, 2017 — Science Translational Medicine has published an article by experts from the Foundation for the National Institutes of Health, the National Institutes of Health, the U.S. Food and Drug Administration (FDA), industry, academia and not-for-profit organizations that outlines a framework for the level of evidence needed to support qualification of biological markers (biomarkers) for use in drug development decision making.
November 30, 2017 — Science has published an article outlining guiding principles for sponsors and supporters of gene drive research agreed upon by 13 organizations thus far, including the Foundation for the National Institutes of Health. Considered an emerging technology still in early research, gene drive can be used to promote the preferential inheritance of a beneficial trait, thereby increasing its prevalence in a population.
July 27, 2017 — The Foundation for the National Institutes of Health (FNIH) is delighted to once again earn the highest, 4-star rating from Charity Navigator, in addition to being named the #1 charity among biomedical research organizations. As America’s largest charity evaluator, Charity Navigator acknowledged the FNIH for demonstrating strong financial health and commitment to accountability and transparency.